Charles Schwab Investment Management Inc Aquestive Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 19,078 shares of AQST stock, worth $49,602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,078
Previous 19,078
-0.0%
Holding current value
$49,602
Previous $38,000
113.16%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AQST
# of Institutions
105Shares Held
42.1MCall Options Held
463KPut Options Held
431K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$25.5 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$14.4 Million2.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.24MShares$8.43 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.22MShares$5.77 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY1.55MShares$4.02 Million0.06% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $139M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...